Antitumor activity of milk kefir and soy milk kefir in tumor-bearing mice

Nutrition and Cancer

Volumn 44, Issue 2, 2002, Pages 183-187

  Liu, Je Ruei ^a   Wang, Sheng Yao ^b   Lin, Yuh Yih ^c   Lin, Chin Wen ^a,d  

^a Department of Animal Science   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d NONE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN; IMMUNOGLOBULIN A; MILK KEFIR; MILK PROTEIN; SOY MILK KEFIR; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY WEIGHT; CANCER GRAFT; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; FERMENTATION; GASTROINTESTINAL INFECTION; HISTOPATHOLOGY; IMMUNOGLOBULIN PRODUCTION; LACTIC ACID BACTERIUM; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; SARCOMA CELL; TUMOR CELL DESTRUCTION; TUMOR VOLUME; ANIMAL; DAIRY PRODUCT; DISEASE MODEL; DRUG EFFECT; DRUG SCREENING; GASTROINTESTINAL TUMOR; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; MUCOSA; PEYER PATCH; SARCOMA; SOYBEAN; STATISTICS;

ANIMALIA; BACTERIA (MICROORGANISMS);

ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; CULTURED MILK PRODUCTS; DISEASE MODELS, ANIMAL; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GASTROINTESTINAL NEOPLASMS; IMMUNOGLOBULIN A; MICE; MICE, INBRED ICR; MUCOUS MEMBRANE; PEYER'S PATCHES; SARCOMA, EXPERIMENTAL; SOYBEANS;

EID: 0038439628     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc4402_10     Document Type: Article

References (31)

1. Reddy GV, Friend BA, Shahani KM, and Farmer RE: Antitumor activity of yogurt components. J Food Prot 46, 8-11, 1983.
2. Bodana AR and Rao DR: Antimutagenic activity of milk fermented by Streptococcus thermophilus and Lactobacillus bulgaricus. J Dairy Sci 73, 3379-3384, 1990.
3. Balansky R, Gyosheva B, Ganchev G, Mircheva Z, Minkova S, et al.: Inhibitory effects of freeze-dried milk fermented by selected Lactobacillus bulgaricus strains on carcinogenesis induced by 1,2-dimethylhydrazine in rats and by diethylnitrosamine in hamsters. Cancer Lett 147, 125-139, 1999.
4. Marshall VM and Cole WM: Methods for making kefir and fermented milks based on kefir. J Dairy Res 52, 451-452, 1985.
5. La Riviere JWM, Kooiman P, and Schmidt K: Kefiran, a novel polysaccharide produced in the kefir grain by Lactobacillus brevis. Arch Microbiol 59, 269-278, 1967.
6. Marshall VM, Cole WM, and Brooker BE: Observations on the structure of kefir grains and the distribution of the microflora. J Appl Bacteriol 57, 491-497, 1984.
7. Angulo L, Lopez E, and Lema C: Microflora present in kefir grains of the Galician region (north-west of Spain). J Dairy Res 60, 263-267, 1993.
8. Lin CW, Chen CL, and Liu JR: Identification and characterisation of lactic acid bacteria and yeasts isolated from kefir grains in Taiwan. Aust J Dairy Technol 54, 14-18, 1999.
9. Messina MJ, Persky V, Setchell KDR, and Barnes S: Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 21, 113-131, 1994.
10. Carroll KK and Kurowska EM: Soy consumption and cholesterol reduction: review of animal and human studies. J Nutr 25, 594S-597S, 1995.
11. Haumann BF: Soymilk: new processing, packaging, expand markets. J Am Oil Chem Soc 61, 1784-1788, 1984.
12. Liu JR and Lin CW: Production of kefir from soymilk with or without added glucose, lactose or sucrose. J Food Sci 65, 716-719, 2000.
13. Liu JR, Chen MJ, and Lin CW: Characterization of polysaccharide and volatile compounds produced by kefir grains grown in soymilk. J Food Sci 67, 104-108, 2002.
14. Kitazawa H, Toba T, Itoh T, Adachi S, and Kumano N: Effects of ropy sour milk on the metastasis of Lewis lung carcinoma in mice. Agric Biol Chem 52, 2331-2332, 1988.
15. Takahashi T, Nakagawa E, Nara T, Yajima T, and Kuwata T: Effects of orally ingested Bifidobacterium longum on the mucosal IgA response of mice to dietary antigens. Biosci Biotechnol Biochem 62, 10-15, 1998.
16. SAS Institute: SAS User's Guide: Statistics. Cary, NC: SAS Institute, 1996.
17. Montgomery DC: Experiments with a single factor: the analysis of variance. In Design and Analysis of Experiments. New York: Wiley, 1991, pp 75-77.
18. Montague LK and Cidlowski NR: Glucocorticoid-induced death of immune cells: mechanisms of action. In Apoptosis in Immunology. New York: Springer-Verlag, 1995, pp 159-170.
19. Ouwehand AC, Kirjavainen PV, Shortt C, and Salminen S: Probiotics: mechanisms and established effects. Int Dairy J 9, 43-52, 1999.
20. Laster SM, Wood JG, and Gooding LR: Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J Immunol 141, 2629-2634, 1988.
21. Fiers W: Tumor necrosis factor: characterization at the molecular, cellular and in vivo levels. FEBS Lett 285, 199-212, 1991.
22. Markovitz J, Linassier C, Fosse P, Couprie J, Pierre J, et al.: Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 49, 5111-5117, 1989.
23. Btrand R: Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and topoisomerase II inhibitors. Exp Cell Res 207, 388-397, 1993.
24. Murrill WB, Brown NM, Zhang JX, Manzolillo PA, Barnes S, et al.: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17, 1451-1457, 1996.
25. Constantinou AI, Mehta RG, and Vaughan A: Inhibition of N-methyl N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res 16, 3293-3298, 1996.
26. Naik HR, Lehr JE, and Pienta KJ: An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer. Anticancer Res 14, 2617-2620, 1994.
27. Yasui H and Ohwaki M: Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium breve. J Dairy Sci 74, 1187-1195, 1990.
28. Heel KA, Mc Cauley RD, Papadimitrion JM, and Hall JC: Review: Peyer's patches. J Gastroenterol Hepatol 12, 122-136, 1997.
29. Fukushima Y, Kawata Y, Mizumachi K, Kurisaki J, and Mitsuoka T: Effect of bifidobacteria feeding on fecal flora and production of immunoglobulins in lactating mouse. Int J Food Microbiol 46, 193-197, 1999.
30. Kitazawa H, Nomura M, Itoh T, and Yamaguchi T: Functional alteration of macrophages by a slime-forming Lactococcus lactis ssp. cremoris. J Dairy Sci 74, 2082-2088, 1991.
31. Kitazawa H, Yamaguchi T, and Itoh T: B-cell mitogenic activity of slime products produced from slime-forming, encapsulated Lactococcus lactis ssp. cremoris. J Dairy Sci 75, 2946-2951, 1992.